Nicholas J Simmonds
Overview
Explore the profile of Nicholas J Simmonds including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
489
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bercusson A, Williams T, Simmonds N, Alton E, Griesenbach U, Shah A, et al.
PLoS Pathog
. 2025 Feb;
21(2):e1012784.
PMID: 39903773
Aspergillus fumigatus (Af) is a major mould pathogen found ubiquitously in the air. It commonly infects the airways of people with cystic fibrosis (CF) leading to Aspergillus bronchitis or allergic...
2.
Altabee R, Mwamba M, Turner D, Davies G, Abbott J, Simmonds N, et al.
J Cyst Fibros
. 2024 Nov;
PMID: 39616120
Background: Cystic fibrosis (CF) is a chronic condition that requires complex and long-term treatments. While substantial research has explored treatment burden associated with CF; its impact remains complex to quantify....
3.
Downey D, Simmonds N, van-Koningsbruggen-Rietschel S, Bend J, Dunlevy F, Hill K, et al.
J Cyst Fibros
. 2024 Nov;
24(1):79-82.
PMID: 39581782
No abstract available.
4.
5.
Altabee R, Carr S, Abbott J, Cameron R, Office D, Simmonds N, et al.
Respir Med Res
. 2024 Sep;
86:101137.
PMID: 39244833
Background: The EQ-5D is the recommended measure to capture health-related quality of life (HRQoL), recognised for use in health technology appraisal bodies. In order to assess whether it is appropriate...
6.
Casey M, Simmonds N
Expert Rev Respir Med
. 2024 Feb;
18(1-2):1-3.
PMID: 38386416
No abstract available.
7.
Sloan C, Sherrard L, Einarsson G, Dupont L, van Koningsbruggen-Rietschel S, Simmonds N, et al.
J Cyst Fibros
. 2024 Feb;
23(3):499-505.
PMID: 38360460
Background: Prescribers have an increasing range of inhaled antimicrobial formulations to choose from when prescribing both eradication and chronic suppression regimens in cystic fibrosis (CF). This study aimed to investigate...
8.
Dobra R, Pinnell S, Jones A, Madge S, Simmonds N, Davies J
J Cyst Fibros
. 2023 Dec;
23(1):68-72.
PMID: 38040535
Understanding the number of patients eligible to participate in research is important to design protocols and define research priorities. We reviewed the records of all patients with CF, age 12+,...
9.
Hanger S, Felton I, Ukor E, Bowman E, Caldwell C, Banya W, et al.
Pediatr Pulmonol
. 2023 Oct;
59(1):221-224.
PMID: 37817743
No abstract available.
10.
Castellani C, Simmonds N, Barben J, Addy C, Bevan A, Burgel P, et al.
J Cyst Fibros
. 2023 Sep;
22(6):963-968.
PMID: 37775442
There is considerable activity with respect to diagnosis in the field of cystic fibrosis (CF). This relates primarily to developments in newborn bloodspot screening (NBS), more extensive gene analysis and...